Skip to content
value.today

Electromed, Inc.

ELMD
$341 Mmarket cap on Aug 1, 2026+270.7% since Jan 2024
Compare
World rank
#14,245
Revenue
$74 M
For year ending June-2026
Net income
$11 M
15.3% margin
SEC filing
Employees
197
As of June 30, 2026
SEC filing

Electromed, Inc. in brief

Electromed, Inc. is a listed company in the Medical Equipment industry, based in New Prague, Minnesota, USA. Its market value was $341 M on 1 August 2026, which makes it the 14,245th largest listed company in the world and the 2,790th largest in the USA on this site. In the year to June 2026 it had sales of $74 M and a net profit of $11 M, about 15 cents of profit for every dollar of sales. It employs about 197 people and James L. Cunniff is its chief executive. Its shares trade under the symbol ELMD (NYSE).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Electromed, Inc.

Electromed, Inc. develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest® Airway Clearance System to patients with compromised pulmonary function with a commitment to excellence and compassionate service. Our goal is to make High Frequency Chest Wall Oscillation treatments as effective, convenient, and comfortable as possible, so our patients can breathe easier and live better with improved respiratory function and fewer exacerbations.

The SmartVest System generates HFCWO, an airway clearance therapy. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective therapy to clear the lung and airway from retained secretions and mucus which can harbor bacteria and lead to infection. One important factor of respiratory health is the ability to clear secretions from airways. Impaired airway clearance, when mucus cannot be expectorated, may result in labored breathing, inflammatory response and/or immune systems boosting mucus production that invites bacteria trapped in stagnant secretions to cause infections. Studies show that HFCWO therapy is as effective an airway clearance method for patients who have compromised pulmonary function as traditional chest physical therapy administered by a respiratory therapist.1 However, HFCWO can be self-administered, relieving a caregiver of participation in the therapy, and eliminating the attendant cost of an in-home care provider. We believe that HFCWO treatments are cost-effective primarily because they reduce a patient’s risk of respiratory infections and other secondary complications that are associated with impaired airway clearance and often result in costly hospital visits and repeated antibiotic use.

From the company's annual report filed with the US SEC: read the report

Electromed, Inc. timeline

4 events, 2010–2026
  1. 2010
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2011
  4. 🔔
    · approximate
    Initial public offering on NYSE
  5. 2026
  6. 💰
    Record revenue of $74 million
    FY2026, the highest of the 9 years on record.
  7. 💰
    Record net income of $11 million
    FY2026, the highest profit of the 9 years on record.

Events of Electromed, Inc. from SEC EDGAR, the company record and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$92 M$184 M$276 M$368 M2020202120222023202420252026

World rank over time

▲ up 6,429 places since 2020
2020-01-01: #20158#20,15820202021-01-01: #18837#18,83720212022-01-07: #22494#22,49420222022-12-25: #22579#22,57920222023-07-30: #22236#22,23620232024-01-05: #21884#21,88420242026-03-08: #9002#9,00220262026-08-01: #13729#13,7292026

Rank in USA: #3,897 (Jan 2020) · #3,791 (Jan 2021) · #4,330 (Jan 2022) · #4,417 (Dec 2022) · #4,312 (Jul 2023) · #3,752 (Jan 2024) · #1,713 (Mar 2026) · #2,774 (Aug 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
28.6×
Price / sales (TTM)
4.5×
Price / book
6.3×
Free cash flow yield
2.5%
Net margin (TTM)
15.8%
Operating margin
18.8%
Return on equity
22.1%
Liabilities / assets
18.5%
Net debt
$-4M
Revenue growth
+15.3%
R&D / revenue
1.8%
Revenue per employee
$375 K
Profit per employee
$57 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Jun 2019: revenue $31M, net income $2M$31MFY19Fiscal year ending Jun 2020: revenue $32M, net income $4M$32MFY20Fiscal year ending Jun 2021: revenue $36M, net income $2M$36MFY21Fiscal year ending Jun 2022: revenue $42M, net income $2M$42MFY22Fiscal year ending Jun 2023: revenue $48M, net income $3M$48MFY23Fiscal year ending Jun 2024: revenue $55M, net income $5M$55MFY24Fiscal year ending Jun 2025: revenue $64M, net income $8M$64MFY25Fiscal year ending Jun 2026: revenue $74M, net income $11M$74MFY26
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Jun 2026$74M+15.3%$14M$11M15.3%
Jun 2025$64M+17.0%$10M$8M11.8%
Jun 2024$55M+13.8%$7M$5M9.4%
Jun 2023$48M+15.4%$4M$3M6.6%
Jun 2022$42M+16.5%$3M$2M5.5%
Jun 2021$36M+10.1%$3M$2M6.6%
Jun 2020$32M+3.7%$5M$4M12.8%
Jun 2019$31M—$3M$2M6.3%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Jun 2026$10M$1M$8M$1.30—
Jun 2025$11M$0M$11M$0.85—
Jun 2024$9M$0M$9M$0.58—
Jun 2023$1M$2M$-0M$0.36—
Jun 2022$-1M$1M$-2M$0.26—
Jun 2021$3M$0M$3M$0.27—
Jun 2020$4M$1M$3M$0.47—
Jun 2019$3M$1M$1M$0.23—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$76M
Net income, trailing 12 months
$12M
RevenueNet income
Three months to Dec 2024: revenue $16M, net income $2M$16MDec ’24Three months to Mar 2025: revenue $16M, net income $2M$16MMar ’25Three months to Jun 2025 (from the annual report): revenue $17M, net income $2M$17MJun ’25Three months to Sep 2025: revenue $17M, net income $2M$17MSep ’25Three months to Dec 2025: revenue $19M, net income $3M$19MDec ’25Three months to Mar 2026: revenue $19M, net income $3M$19MMar ’26Three months to Jun 2026 (from the annual report): revenue $19M, net income $3M$19MJun ’26Three months to Sep 2026: revenue $19M, net income $3M$19MSep ’26

Latest quarter to Sep 2026: revenue $19M (+10.6% on a year earlier), net income $3M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Electromed, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$74 M
Operating income
$14 M
Net income
$11 M

For year ending June-2026 · source: SEC filing

Balance sheet

Total assets
$66 M
Total liabilities
$12 M
Total equity
$54 M

As of June-2026

Top 100 institutional investors in Electromed, Inc.#

As of Sep 30, 2026
126 institutions held 4.8 M shares (about 59.2% of the shares outstanding) on Sep 30, 2026. The ten largest hold 30.8%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Electromed, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.476,970+11,351 (+2.44%)5.84%$13 MNov 13, 2026
2J.E. Simmons & Co., P.C.468,322-15,500 (-3.20%)5.73%$13 MNov 12, 2026
3Vanguard Capital Management LLC285,658+2,426 (+0.86%)3.49%$8 MNov 13, 2026
4Geode Capital Management, LLC269,104+51,989 (+23.95%)3.29%$8 MNov 6, 2026
5Punch & Associates Investment Management, Inc.196,332-22,188 (-10.15%)2.40%$6 MNov 16, 2026
6Acadian Asset Management LLC183,489-38,356 (-17.29%)2.24%$5 MNov 9, 2026
7Dimensional Fund Advisors LP181,399+952 (+0.53%)2.22%$5 MNov 4, 2026
8Two Sigma Investments, LP158,157-9,335 (-5.57%)1.93%$4 MNov 16, 2026
9Hunter Associates Investment Management LLC157,278+1,400 (+0.90%)1.92%$4 MOct 26, 2026
10Arrowstreet Capital, Limited Partnership143,632+76,834 (+115.02%)1.76%$4 MNov 13, 2026
11GAMCO Investors, Inc. Et Al142,0000 (0.00%)1.74%$4 MNov 12, 2026
12Renaissance Technologies LLC128,514+28,810 (+28.90%)1.57%$4 MNov 12, 2026
13State Street Corp110,913-1,703 (-1.51%)1.36%$3 MNov 12, 2026
14Vanguard Portfolio Management LLC104,124+19,827 (+23.52%)1.27%$3 MNov 13, 2026
15Goldman Sachs Group Inc98,352+25,648 (+35.28%)1.20%$3 MNov 16, 2026
16Lazard Asset Management LLC96,579+3,107 (+3.32%)1.18%$3 MNov 16, 2026
17Northern Trust Corp85,075+937 (+1.11%)1.04%$2 MNov 16, 2026
18Qube Research & Technologies Ltd79,210+44,864 (+130.62%)0.97%$2 MNov 13, 2026
19White Pine Capital LLC69,937-63 (-0.09%)0.86%$2 MNov 9, 2026
20Morgan Stanley66,548+21,368 (+47.30%)0.81%$2 MNov 13, 2026
21Man Group plc64,017+26,168 (+69.14%)0.78%$2 MNov 16, 2026
22Bridgeway Capital Management, LLC52,302-5,261 (-9.14%)0.64%$1 MNov 16, 2026
23Vanguard Fiduciary Trust Co50,973+1,242 (+2.50%)0.62%$1 MNov 13, 2026
24Bank of New York Mellon Corp47,933+1,911 (+4.15%)0.59%$1 MNov 5, 2026
25Ameriprise Financial Inc46,123+3,780 (+8.93%)0.56%$1 MNov 16, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Electromed, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Y-Intercept (Hong Kong) Ltd42,854New0.52%$1 MOct 16, 2026
27Raymond James Financial Inc41,883-2,812 (-6.29%)0.51%$1 MNov 12, 2026
28Isthmus Partners, LLC41,544New0.51%$1 MOct 21, 2026
29BNP Paribas Financial Markets39,740-3,275 (-7.61%)0.49%$1 MNov 12, 2026
30Oak Ridge Investments LLC39,511+247 (+0.63%)0.48%$1 MOct 30, 2026
31Globeflex Capital L P35,4700 (0.00%)0.43%$1 MNov 16, 2026
32North Star Investment Management Corp.34,0000 (0.00%)0.42%$1 MOct 27, 2026
33Bernicke Wealth Management, Ltd.32,6220 (0.00%)0.40%$1 MNov 6, 2026
34AQR Capital Management LLC32,438-4,703 (-12.66%)0.40%$1 MNov 16, 2026
35Gabelli Funds LLC30,7000 (0.00%)0.38%$1 MNov 12, 2026
36NLB Skladi, upravljanje premozenja, d.o.o.30,2630 (0.00%)0.37%$1 MOct 22, 2026
37Jpmorgan Chase & Co28,274+2,611 (+10.17%)0.35%$1 MNov 12, 2026
38Strs Ohio26,300+9,100 (+52.91%)0.32%$1 MOct 30, 2026
39LPL Financial LLC22,128+704 (+3.29%)0.27%$1 MNov 6, 2026
40Quadrature Capital Ltd21,211+9,920 (+87.86%)0.26%$1 MNov 13, 2026
41Aristides Capital LLC20,383-15,639 (-43.42%)0.25%$1 MNov 16, 2026
42Charles Schwab Investment Management Inc20,299+940 (+4.86%)0.25%$1 MNov 16, 2026
43Teton Advisors, LLC20,0000 (0.00%)0.24%$1 MNov 12, 2026
44Magnetar Financial LLC19,966New0.24%$1 MNov 13, 2026
45Corsair Capital Management, L.P.19,374-1,200 (-5.83%)0.24%$1 MNov 16, 2026
46Los Angeles Capital Management LLC18,863-7,545 (-28.57%)0.23%$1 MNov 12, 2026
47Voya Investment Management LLC17,1830 (0.00%)0.21%$0 MNov 10, 2026
48O'shaughnessy Asset Management, LLC17,016+10,488 (+160.66%)0.21%$0 MNov 12, 2026
49Squarepoint Ops LLC16,630-2,868 (-14.71%)0.20%$0 MNov 9, 2026
50American Century Companies Inc15,768+2,074 (+15.15%)0.19%$0 MNov 12, 2026
51Empowered Funds, LLC15,539New0.19%$0 MNov 13, 2026
52Polar Asset Management Partners Inc.15,000New0.18%$0 MNov 16, 2026
53Ritholtz Wealth Management14,436+8,843 (+158.11%)0.18%$0 MNov 5, 2026
54FMR LLC14,351+12,305 (+601.42%)0.18%$0 MNov 10, 2026
55Bridge City Capital, LLC13,9740 (0.00%)0.17%$0 MOct 29, 2026
56Nuveen, LLC13,835+677 (+5.15%)0.17%$0 MNov 10, 2026
57Victory Capital Management Inc13,718New0.17%$0 MNov 10, 2026
58Wells Fargo & Company/mn12,515+6,423 (+105.43%)0.15%$0 MNov 16, 2026
59Jane Street Group, LLC11,972New0.15%$0 MNov 12, 2026
60Integrated Quantitative Investments LLC11,757New0.14%$0 MNov 13, 2026
61Public Employees Retirement System Of Ohio11,744New0.14%$0 MNov 16, 2026
62Citadel Advisors LLC11,657-30,388 (-72.27%)0.14%$0 MNov 16, 2026
63UBS Group AG11,212-3,275 (-22.61%)0.14%$0 MNov 10, 2026
64Gsa Capital Partners LLP10,728+1,827 (+20.53%)0.13%$0 MNov 16, 2026
65Simplicity Wealth,LLC10,640New0.13%$0 MOct 23, 2026
66HSBC Holdings PLC10,623-1,163 (-9.87%)0.13%$0 MNov 16, 2026
67Sprott Inc.10,0000 (0.00%)0.12%$0 MNov 9, 2026
68NewEdge Advisors, LLC9,995+3,491 (+53.67%)0.12%$0 MNov 13, 2026
69Martingale Asset Management L P9,649+605 (+6.69%)0.12%$0 MNov 12, 2026
70Verdad Advisers, LP9,513New0.12%$0 MNov 16, 2026
71Barclays PLC9,486+1,629 (+20.73%)0.12%$0 MNov 6, 2026
72HRT Financial LP8,960New0.11%$0 MNov 13, 2026
73Bank Of America Corp /de/8,907-28,843 (-76.41%)0.11%$0 MNov 16, 2026
74XTX Topco Ltd8,595+2,119 (+32.72%)0.11%$0 MNov 16, 2026
75Rhumbline Advisers8,584+338 (+4.10%)0.10%$0 MNov 10, 2026
76Allspring Global Investments Holdings, LLC8,562+338 (+4.11%)0.10%$0 MNov 4, 2026
77Legacy Wealth Asset Management, LLC8,5500 (0.00%)0.10%$0 MOct 9, 2026
78Occudo Quantitative Strategies LP8,171+2,820 (+52.70%)0.10%$0 MNov 16, 2026
79Invesco Ltd.8,057-43,337 (-84.32%)0.10%$0 MNov 12, 2026
80Hillsdale Investment Management Inc.8,0000 (0.00%)0.10%$0 MNov 12, 2026
81Pathstone Holdings, LLC7,564+3 (+0.04%)0.09%$0 MNov 13, 2026
82State Of Wisconsin Investment Board7,408New0.09%$0 MNov 16, 2026
83Deutsche Bank AG\5,800-834 (-12.57%)0.07%$0 MNov 6, 2026
84Spire Wealth Management4,4050 (0.00%)0.05%$0 MOct 30, 2026
85MetLife Investment Management, LLC4,2790 (0.00%)0.05%$0 MNov 16, 2026
86IFP Advisors, Inc4,019-4 (-0.10%)0.05%$0 MOct 16, 2026
87New York State Common Retirement Fund3,6000 (0.00%)0.04%$0 MNov 17, 2026
88Russell Investments Group, Ltd.3,416+1,476 (+76.08%)0.04%$0 MNov 6, 2026
89MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,220+145 (+4.72%)0.04%$0 MNov 16, 2026
90Police & Firemen's Retirement System of New Jersey2,561+1,108 (+76.26%)0.03%$0 MNov 9, 2026
91Vanguard Global Advisers, LLC2,473+31 (+1.27%)0.03%$0 MNov 13, 2026
92Legal & General Group Plc1,9420 (0.00%)0.02%$0 MNov 16, 2026
93State of Wyoming1,735New0.02%$0 MOct 28, 2026
94Royal Bank Of Canada1,628+722 (+79.69%)0.02%$0 MNov 16, 2026
95Financial Management Professionals, Inc.1,0990 (0.00%)0.01%$0 MOct 23, 2026
96UMB Private Wealth Management, LLC1,002—0.01%$0 MOct 19, 2026
97Citigroup Inc976-2,776 (-73.99%)0.01%$0 MNov 4, 2026
98State of Alaska, Department of Revenue7850 (0.00%)0.01%$0 MOct 15, 2026
99PNC Financial Services Group, Inc.728+28 (+4.00%)0.01%$0 MNov 6, 2026
100Ameritas Investment Partners, Inc.7040 (0.00%)0.01%$0 MNov 13, 2026

All 126 institutional investors, with who bought and sold →

Mutual funds holding Electromed, Inc.#

109 funds hold shares worth $59 M (about 17.3% of the company). Since their previous reports 44 added shares and 29 sold, selling $1 M net.
Mutual funds holding Electromed, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.197,135$8 M2.4%<0.01%−20%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors170,748$7 M2.1%<0.01%+7.9%Jun 30, 2026
🇺🇸 1290 VT GAMCO Small Company Value PortfolioEquitable Investment Management Group, LLC142,000$6 M1.7%0.13%no changeJun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.79,217$3 M0.97%<0.01%−0.4%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC72,891$3 M0.89%<0.01%+9.4%Jul 31, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors62,716$3 M0.77%0.02%+13%Jun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP45,979$2 M0.56%<0.01%no changeJul 31, 2026
🇺🇸 Small Company Growth PortfolioThe Vanguard Group, Inc.38,144$2 M0.47%0.10%no changeJun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC35,963$1 M0.44%<0.01%−2.6%May 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.34,829$1 M0.43%<0.01%+4.1%May 31, 2026
🇺🇸 North Star Micro Cap FundNorth Star Investment Management Corp.34,000$1 M0.42%0.70%newMay 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP29,778$1 M0.36%0.02%no changeJul 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP27,435$1 M0.34%<0.01%+1.6%Jul 31, 2026
🇺🇸 The Gabelli Small Cap Growth FundGabelli Funds, LLC22,500$1 M0.28%0.05%−21%Jun 30, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors22,445$1 M0.27%0.06%+32%Jun 30, 2026
🇺🇸 TETON Westwood Mighty Mites FundTeton Advisors, LLC20,000$1 M0.24%0.39%no changeJun 30, 2026
🇺🇸 Strategic Advisers Fidelity U.S. Total Stock FundStrategic Advisers LLC21,516$1 M0.26%<0.01%+5.9%May 31, 2026
🇺🇸 Acuitas US Microcap FundAcuitas Investments, LLC17,376$1 M0.21%0.62%—Jun 30, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC15,800$1 M0.19%0.45%−11%Jun 30, 2026
🇺🇸 Voya Index Plus Smallcap PortfolioVoya Investments, LLC15,661$1 M0.19%0.16%+1.2%Jun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.15,756$1 M0.19%<0.01%+7.2%Jul 31, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC16,055$1 M0.20%<0.01%+6.1%May 31, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP13,044$1 M0.16%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC13,987$1 M0.17%<0.01%no changeMay 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC11,954$1 M0.15%<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.11,056$0 M0.14%<0.01%+151%Jun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust10,908$0 M0.13%0.01%no changeMay 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC10,596$0 M0.13%<0.01%+4.4%May 31, 2026
🇺🇸 U.S. Small Cap Growth PortfolioDimensional Fund Advisors LP9,743$0 M0.12%0.02%no changeJul 31, 2026
🇺🇸 Avantis U.S. Small Cap Value ETFAmerican Century ETF Trust10,245$0 M0.13%<0.01%−65%May 31, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.8,961$0 M0.11%0.10%−3.2%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC8,992$0 M0.11%<0.01%no changeJul 31, 2026
🇺🇸 SIMT Small Cap Growth FundSEI Institutional Managed Trust8,459$0 M0.10%0.11%newJun 30, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.9,466$0 M0.12%0.04%+1.3%May 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC7,543$0 M0.09%<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P.6,892$0 M0.08%0.09%+24%Jul 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP6,646$0 M0.08%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC6,248$0 M0.08%0.02%+21%Jun 30, 2026
🇺🇸 Nationwide Bailard Small Cap Value FundNATIONWIDE FUND ADVISORS6,434$0 M0.08%0.20%newJul 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.6,421$0 M0.08%0.01%+3.1%May 31, 2026
🇺🇸 Allspring Disciplined Small Cap FundAllspring Funds Management, LLC5,504$0 M0.07%0.13%+7.0%Jun 30, 2026
🇺🇸 WisdomTree U.S. SmallCap FundWisdomTree Asset Management, Inc.5,354$0 M0.07%0.03%−2.3%Jun 30, 2026
🇺🇸 SIMT Small Cap FundSEI Institutional Managed Trust5,052$0 M0.06%0.04%+314%Jun 30, 2026
🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP5,226$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation4,700$0 M0.06%<0.01%−7.8%Jun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.3,905$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC3,785$0 M0.05%<0.01%+17%Jul 31, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.3,464$0 M0.04%<0.01%−5.3%Jun 30, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.3,594$0 M0.04%<0.01%no changeJul 31, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC3,169$0 M0.04%<0.01%+3.6%Jul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.2,975$0 M0.04%<0.01%−29%Jun 30, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP2,971$0 M0.04%<0.01%+37%Jul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC2,600$0 M0.03%<0.01%+37%Jun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC2,583$0 M0.03%0.01%no changeJun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.2,500$0 M0.03%<0.01%+19%Jun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company2,701$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC2,491$0 M0.03%<0.01%−1.7%Jul 31, 2026
🇺🇸 Invesco Russell 2000 Dynamic Multifactor ETFInvesco Capital Management LLC2,570$0 M0.03%0.03%+171%May 31, 2026
🇺🇸 U.S. Sustainability Core 1 PortfolioDimensional Fund Advisors LP2,300$0 M0.03%<0.01%no changeJul 31, 2026
🇺🇸 SA U.S. Small Company FundFocus Advisor Solutions, LLC2,175$0 M0.03%0.03%no changeJun 30, 2026
🇺🇸 Venerable US Small Cap FundVenerable Investment Advisers, LLC1,791$0 M0.02%0.05%−2.9%Jun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC1,789$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC1,700$0 M0.02%<0.01%−5.6%Jun 30, 2026
🇺🇸 Avantis U.S. Equity ETFAmerican Century ETF Trust1,899$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC1,665$0 M0.02%0.01%newJun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS1,605$0 M0.02%<0.01%+29%Jun 30, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC1,531$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC1,533$0 M0.02%<0.01%−0.8%Jun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC1,504$0 M0.02%0.03%+22%Jun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC1,475$0 M0.02%<0.01%+6.7%Jun 30, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC1,373$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.1,330$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC1,300$0 M0.02%<0.01%+117%Jun 30, 2026
🇺🇸 LVIP Dimensional U.S. Core Equity 2 FundLincoln Financial Investments Corporation1,109$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP1,107$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.1,053$0 M0.01%<0.01%+14%Jun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC1,031$0 M0.01%<0.01%+22%Jun 30, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC1,047$0 M0.01%0.01%−0.9%Jul 31, 2026
🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC1,031$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP957$0 M0.01%<0.01%+158%Jul 31, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.907$0 M0.01%<0.01%+39%Jun 30, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP895$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC860$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS854$0 M0.01%<0.01%−33%Jul 31, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC794$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC816$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.792$0 M<0.01%<0.01%+1.1%Jul 31, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC784$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management704$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP659$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC612$0 M<0.01%0.02%+25%Jun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity FundAmerican Century ETF Trust681$0 M<0.01%0.02%no changeMay 31, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS603$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC576$0 M<0.01%<0.01%+13%Jul 31, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC548$0 M<0.01%0.01%newJun 30, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC512$0 M<0.01%<0.01%+13%Jun 30, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC490$0 M<0.01%<0.01%−14%Jun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.511$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC357$0 M<0.01%<0.01%−41%Jun 30, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC318$0 M<0.01%<0.01%+8.5%May 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Electromed, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$2.2 M
9 sales, 3 insiders
Net, 12 months
-$2.2 M
open market only
Insiders on file
25
since
$302 K-$5.5 M$0Nov 2023: bought $11 K (1 trades), sold $0 (0 trades)Nov 23Dec 2023: bought $302 K (1 trades), sold $0 (0 trades)Mar 2024: bought $137 K (1 trades), sold $0 (0 trades)MarNov 2024: bought $0 (0 trades), sold $4.2 M (3 trades)Dec 2024: bought $0 (0 trades), sold $3.0 M (13 trades)DecFeb 2025: bought $0 (0 trades), sold $5.5 M (14 trades)Sep 2025: bought $0 (0 trades), sold $1.6 M (5 trades)SepMay 2026: bought $0 (0 trades), sold $1.4 M (4 trades)Jun 2026: bought $0 (0 trades), sold $783 K (5 trades)Jun
Bought (open market)Sold (open market)Hover a month for the totals
Electromed, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed James L. CunniffCEO and President, DirectorShares withheld for tax-2,671$27.10$72 K145,080Form 4
filed Bradley M. NagelChief Financial OfficerGrant or award+4,900——23,864Form 4
filed Bradley M. NagelChief Financial OfficerShares withheld for tax-1,102$27.10$30 K22,762Form 4
filed Bradley M. NagelChief Financial OfficerShares withheld for tax-674$42.30$29 K18,964Form 4
filed James L. CunniffCEO and President, DirectorOption exercise+9,700$17.25$167 K157,451Form 4
filed James L. CunniffCEO and President, DirectorSell-7,003$36.25$254 K150,448Form 4
filed James L. CunniffCEO and President, DirectorSell-1,671$36.80$61 K148,777Form 4
filed James L. CunniffCEO and President, DirectorSell-1,026$37.77$39 K147,751Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Electromed, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
180,632
2.2% of shares · 4.77 days to cover
Buybacks, Q3 2026
$4.3M
Q1 2027
Shares sold short, last 24 reportsAll stocks →
Electromed, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2026Q1 2027$4.3M
Q2 2026Q4 2026$0M
Q1 2026Q3 2026$0.2M
Q4 2025Q2 2026$2.8M
Q3 2025Q1 2026$1M
Q2 2025Q4 2025$3.7M
Q1 2025Q3 2025$1.8M
Q4 2024Q2 2026$0M
Q3 2024Q1 2025$4.5M
Q2 2024Q4 2024$0.3M
Q2 2023Q4 2023$0M
Q1 2023Q3 2023$0M
Q4 2022Q2 2022$0M
Q3 2022Q1 2022$0.1M
Q2 2022Q4 2022$0.5M
Q1 2022Q3 2023$0.3M

Fails to deliver

  • : 19 shares at $40.00
  • : 36 shares at $42.58
  • : 1,053 shares at $42.19
  • : 29 shares at $42.04
  • : 33 shares at $41.87

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Electromed, Inc. scorecard#

Passes 15 of the 16 checks that could be worked out: strongest in profitability (5 of 5), weakest in growth (5 of 6). Fiscal year 2026; market cap of Aug 1, 2026.

  • Valuationnot known
    • –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
    • –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
    • –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
  • Growth5 of 6
    • ✓Revenue grew in the newest year15.3%Revenue up 15.3% in fiscal 2026.
    • ✓Revenue up more than 5% a year over three years15.3%15.3% a year over the three years to fiscal 2026.
    • ✗Faster growth over three years than its peers' median15.3%15.3% a year against Medical Equipment's median of 24.7% (5 companies).
    • ✓Earnings per share grew in the newest year1.30 vs 0.85Diluted EPS 1.30 in fiscal 2026 against 0.85 the year before (report's currency).
    • ✓Net income higher than five years earlier$11 M$11 M in fiscal 2026 against $2 M in 2021.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2026.
  • Profitability5 of 5
    • ✓Profitable in the newest year$11 MNet income $11 M in fiscal 2026.
    • ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2026.
    • ✓Operating margin above its peers' median18.8%18.8% against Medical Equipment's median of -38.5% (8 companies).
    • ✓Return on equity above 15%23.2%23.2% in fiscal 2026.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier18.8%18.8% in fiscal 2026 against 8.3% in 2023.
  • Financial health3 of 3
    • ✓Short-term assets cover short-term liabilities4.7×Current ratio 4.69 at the end of fiscal 2026.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2026.
    • ✓Altman Z-score outside the distress zone19.87Z-score 19.87 (safe zone) for fiscal 2026.
  • Shareholder returns2 of 2
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year-2.5%Diluted shares down 2.5% in fiscal 2026.
    • –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
    • ✓Free cash flow covers dividends and buybacks$8 MFree cash flow $8 M against $4 M paid out in fiscal 2026.

Worked out from the statements as filed (sec), the medians of Medical Equipment, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2026#

Worked out from Electromed, Inc.'s statements, beside the median of Medical Equipment.

Electromed, Inc.: main financial ratios in 2026
Ratio2026Median of peers
Operating margin18.8%-38.5%
Net margin15.3%-44.9%
Return on equity23.3%-94.5%
Revenue growth, 3 years a year15.4%24.7%
Revenue growth15.3%15.6%
Free cash flow margin11.4%-35.7%

5of 8on the Piotroski tests of financial strength

  • Revenue has grown 13 years in a row.
  • The share count fell 2.5% in the year (buybacks).

Electromed, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Electromed, Inc.: statements by fiscal year
PeriodTrendFY 2026to Jun 30, 2026FY 2025to Jun 30, 2025FY 2024to Jun 30, 2024FY 2023to Jun 30, 2023FY 2022to Jun 30, 2022FY 2021to Jun 30, 2021FY 2020to Jun 30, 2020FY 2019to Jun 30, 2019FY 2018to Jun 30, 2018FY 2017to Jun 30, 2017
Income statement
Revenue73,77664,00054,71648,06741,65935,75632,471r31,30028,307r25,861
Cost of revenue15,83314,02912,99011,54810,2178,4517,271r7,4526,534r5,293
Gross profit57,94349,97141,72636,51931,44227,30525,200r23,84821,773r20,568
Research and development1,3149966569161,3561,7221,050r583251597
Selling, general and administrative42,74839,31534,48931,59527,11422,44319,945r20,435r18,809r16,402
Operating expenses44,06240,31135,14532,51128,47024,16520,082r21,018r19,060r16,999
Operating income13,8819,6606,5814,0082,9723,1405,118r2,830r2,712r3,569
Interest and finance income—————————17
Net interest income——455782527r121r9120−50
Income before tax14,36010,2847,0364,0862,9973,1675,239r2,920r2,732r3,519
Income tax3,0592,7471,8869206928051,078940901r1,290
Net income attributable to shareholders11,3017,5375,1503,1662,3052,3624,161r1,980r1,831r2,229
Earnings per share, basic1.370.890.600.370.270.280.500.240.22r0.27
Earnings per share, diluted1.300.850.580.360.260.270.470.230.21r0.26
Shares, weighted average (basic)8.38.58.68.58.58.68.48.38.28.2
Shares, weighted average (diluted)8.78.98.98.78.88.98.88.68.68.5
Balance sheet
Cash and cash equivalents20,45015,28716,0807,3728,15311,88910,479r7,808r7,4565,574
Receivables29,80524,66023,33324,13021,05217,03212,941r12,76011,811r9,950
Inventory3,6813,2993,7124,2213,1782,1143,085r2,6222,487r2,559
Other current assets1,1703923291,5771,870276353r353757r393
Current assets57,36845,08244,17337,78734,53931,70428,023r24,53923,288r18,476
Property, plant and equipment5,2144,7145,1655,6724,5683,6053,788r3,6053,0913,303
Right-of-use (leased) assets13119887—1208881r45——
Other intangible assets379371657605599663598r581r649r721r
Total assets66,26753,80252,23445,80641,36437,10933,245r29,399r27,392r23,061
Accounts payable2,6432,6671,0101,3721,261685556r587811663
Debt due within a year—————3372r3030r51
Current liabilities12,22210,4687,6778,0537,1504,6392,986r3,651r4,803r2,896
Long-term debt—————————1,097
Total liabilities12,28810,5937,6898,1397,1914,6932,995r3,6654,7433,993
Retained earnings28,56421,18523,66818,79315,78014,92213,684r9,522r9,522r4,957
Shareholders' equity53,97943,20944,54537,66734,17332,41630,250r25,735r22,578r19,833r
Total liabilities and equity66,26753,80252,23445,80641,36437,10933,245r29,399r27,392r23,061
Shares outstanding8.48.38.68.6r8.58.58.68.48.38.2
Cash-flow statement
Share-based compensation2,7223,0591,6927089761,024902r924863479
Cash from operating activities9,66511,3939,0671,315−6863,0774,196r2,5902,4421,191
Capital expenditure−1,252−262−287−1,648−1,425−287−844r−1,331−526−619
Intangible assets bought−48−44−108−68−100−161−133r−58−46−68
Cash from investing activities−1,300−306−395−1,716−1,525−448−977r−1,387−572−687
Shares bought back−3,918−10,000−275−153−1,448−1,124————
Cash from financing activities−3,202−11,88036−380−1,525−1,219−548r−85112−54
Change in cash5,163−7938,708−781−3,7361,4102,671r352——
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Electromed, Inc. sells: revenue by product line, fiscal 2026#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2025. Lines can overlap (a total and its parts), so they are not added up.

Countries and regions

  • Non-US(total)$0 M0.6%

Source: SEC annual report (XBRL data) · as of Jun 30, 2026

Executive pay at Electromed, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2026
$1.8 M
James L. Cunniff
Other top executives, average
$836 K
the CEO earned 2.2× this
$100 invested is now
$395
Electromed, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2026James L. Cunniff$1.8 M$4.3 M$836 K$395
2025James L. Cunniff$1.5 M$4.9 M$757 K$205
2024James L. Cunniff$3.0 M$4.4 M$553 K$140

Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2026

Events at Electromed, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 1 · Material agreement 2 · New debt 2 · Bylaws or fiscal year changed 1 · Shareholder vote 3 · Results announced 13

Electromed, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Directors and officersResults announced8-K
Results announced8-K
Results announced8-K
Material agreementNew debt8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Bylaws or fiscal year changedShareholder vote8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Material agreementNew debt8-K
Shareholder vote8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 10, 2026

How Electromed, Inc. compares in Medical Equipment

  • Market cap$341 M · higher than 71% of 8
  • Revenue$74 M · higher than 44% of 19
  • Net margin15.8% · highest of 17
  • Revenue growth15.3% · higher than 58% of 13
  • Price / sales4.5× · lower than 33% of 7
  • Price / book6.3× · lower than 17% of 7
  • FCF yield2.5% · higher than 83% of 7

Peer comparison · Medical Equipment

CompanyMarket capP/ENet marginRev. growth
Electromed, Inc.🇺🇸$341 M28.6×15.8%+15.3%
Avita Medical, Inc.🇺🇸$525 M—-42.6%+11.5%
Viemed Healthcare, Inc.🇺🇸$367 M23.5×5.0%+20.5%
Profound Medical Corp.🇨🇦$240 M—-137.4%+50.8%
Streamex Corp.🇺🇸$52 M——+100.0%
TELA Bio, Inc.🇺🇸$52 M—-53.6%+15.8%
IRIDEX Corporation🇺🇸$12 M—-6.9%+8.2%
Beyond Air, Inc.🇺🇸$4 M—-407.6%+107.6%
Varian Medical Systems🇺🇸$16.3 B—8.5%-1.8%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Aug 1, 2026
Annual results:
For year ending June-2026
Balance sheet:
As of June-2026
Employees:
As of June 30, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Electromed, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Electromed, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Electromed, Inc.? Suggest a correction